Is it Right Time Pull the Trigger on HealthEquity Inc. [HQY] Stock?

HealthEquity Inc. [HQY] stock is down -2.20 while the S&P 500 has risen 0.09% on Monday, 12/07/20. While at the time of this article, HQY ATR is sitting at 3.31, with the beta value at 1.57. This stock’s volatility for the past week remained at 4.38%, while it was 5.05% for the past 30-day period. HQY has fallen -$1.51 from the previous closing price of $68.75 on volume of 0.82 million shares.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


On 7, December 2020, HealthEquity Reports Third Quarter Ended October 31, 2020 Financial Results. According to news published on Yahoo Finance, Highlights of the third quarter include:.

Analyst Birdseye View:

The most recent analyst activity for HealthEquity Inc. [NASDAQ:HQY] stock was on December 02, 2020, when it was Downgrade with a Sector weight rating from KeyBanc Capital Markets. Before that, on December 08, 2020, Barrington Research Recapitulated an Outperform rating and elevated its amount target to $75. On November 23, 2020, Guggenheim Downgrade a Neutral rating. On October 23, 2020, RBC Capital Mkts Initiated an Outperform rating and increased its price target to $67. On April 14, 2020, Guggenheim Initiated a Buy rating and increased its price target to $56. On April 13, 2020, SVB Leerink Initiated a Mkt perform rating. On March 17, 2020, Barrington Research Reiterated an Outperform rating and decreased its target amount on this stock from $86 to $65. On October 07, 2019 Goldman Initiated a Neutral rating and elevated its amount target to $56.

In the past 52 weeks of trading, this stock has oscillated between a low of $34.40 and a peak of $88.78. Right now, the middling Wall Street analyst 12-month amount mark is $73.00. At the most recent market close, shares of HealthEquity Inc. [NASDAQ:HQY] were valued at $67.24. According to the average price forecast, investors can expect a potential return of 5.71%.


HealthEquity Inc. [NASDAQ:HQY] most recently reported quarterly sales of 176.04 billion, which represented growth of 103.20%. This publicly-traded organization’s revenue is $181,506 per employee, while its income is $13,533 per employee. This company’s Gross Margin is currently 57.90%, its Operating Margin is 2.10%, its Pretax Margin is +8.11, and its Net Margin is +7.46. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 2.58, 5.26, 7.77 and 2.88 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 55.81 and the whole liability to whole assets at 50.73. It shows enduring liability to the whole principal at 53.60 and enduring liability to assets at 0.49 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 67.63 points at 1st support level, the second support level is making up to 66.52. But as of 1st resistance point, this stock is sitting at 70.28 and at 71.82 for 2nd resistance point.

HealthEquity Inc. [HQY] reported its earnings at $0.41 per share in the fiscal quarter closing of 10/30/2020. The Analysts for Wall Street were expecting to report its earnings at $0.36/share signifying the difference of 0.05 and 13.90% surprise value. Comparing the previous quarter ending of 7/30/2020, the stated earnings were $0.42 calling estimates for $0.27/share with the difference of 0.15 depicting the surprise of 55.60%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for HealthEquity Inc. [NASDAQ:HQY] is 2.50. Likewise, the Quick ratio is also the same, showing Cash ratio at 1.26. Now if looking for a valuation of this stock’s amount to sales ratio it’s 8.50 and it’s amount to book ratio is 4.56.

Insider Stories

The most recent insider trade was by Medici Frank, Director, and it was the sale of 10148.0 shares on Nov 18. Dreier Ashley, the Former Exec, VP, CTO and CIO, completed a sale of 16250.0 shares on Sep 02. On Jun 05, Hill Angelique Christine, Exec VP, Operations, completed a sale of 11091.0 shares.